Over the past decade, robotic neurorehabilitation has become one of the most discussed innovations in neurological recovery. Robotic gait trainers, upper-limb rehabilitation systems, exoskeletons, and AI-assisted rehabilitation devices are increasingly being adopted by hospitals and rehabilitation centres worldwide. However, an important question remains: Are robots the future of neurorehabilitation—or are they simply another tool in the rehabilitation toolbox? As clinicians and researchers, we must move beyond marketing claims and focus on scientific evidence, patient selection, and clinical reasoning. What is Robotic Neurorehabilitation? Robotic neurorehabilitation involves the use of electromechanical devices that assist, guide, resist, or augment movement during therapy. These technologies include: • Robotic gait trainers • Wearable exoskeletons • Upper limb robotic rehabilitation devices • End-effector robotic systems • Sensor-based rehabilitation platforms • AI-assiste...
Abnormal synaptic
homeostasis is a key feature observed in individuals with autism spectrum
disorders (ASD), contributing to the cognitive and behavioral impairments
associated with the condition. Here is an overview of the abnormal synaptic
homeostasis in ASD:
1. Synaptic
Dysfunction in Autism:
o Excitatory-Inhibitory
Imbalance:
Individuals with ASD often exhibit an imbalance between excitatory and
inhibitory neurotransmission, leading to altered synaptic activity and neural
circuit function. This imbalance can affect information processing, sensory
integration, and cognitive functions in individuals with ASD [T10].
o Altered Synaptic
Plasticity:
Impairments in synaptic plasticity mechanisms, such as long-term potentiation
(LTP) and long-term depression (LTD), have been reported in ASD. Dysregulation
of synaptic plasticity can impact learning and memory processes, as well as
social and communication skills in individuals with ASD [T11].
o Synaptic Pruning
Abnormalities: Atypical synaptic pruning, the process by which unnecessary synapses are
eliminated during development, has been observed in ASD. Disruptions in
synaptic pruning can lead to aberrant connectivity patterns, altered neural
networks, and impaired information processing in the brain [T12].
2.Molecular
Mechanisms Underlying Abnormal Synaptic Homeostasis:
o Dysregulation of
Synaptic Proteins: Mutations in genes encoding synaptic proteins, such as neuroligins,
neurexins, and Shank family proteins, have been implicated in ASD. Alterations
in these synaptic proteins can disrupt synaptic structure, function, and
plasticity, contributing to abnormal synaptic homeostasis in individuals with
ASD [T13].
oAltered
Neurotransmitter Systems: Dysfunctions in neurotransmitter systems, including glutamate, GABA,
serotonin, and dopamine, have been linked to synaptic abnormalities in ASD.
Imbalances in neurotransmission can affect synaptic signaling, neuronal
excitability, and synaptic plasticity mechanisms in individuals with
ASD [T14].
oImmune-Mediated
Synaptic Dysfunction: Immune dysregulation and neuroinflammation have been associated with
synaptic abnormalities in ASD. Immune-mediated synaptic dysfunction can lead to
synaptic pruning deficits, altered synaptic connectivity, and impaired neural
communication in individuals with ASD [T15].
3. Therapeutic
Implications:
oTargeting
Synaptic Function: Therapeutic strategies aimed at modulating synaptic function and
plasticity, such as NMDA receptor modulators, GABAergic agents, and synaptic
protein regulators, may help restore synaptic homeostasis and improve cognitive
and behavioral outcomes in individuals with ASD [T16].
oNeurotransmitter
Modulation:
Pharmacological interventions targeting neurotransmitter systems implicated in
synaptic dysfunction, such as glutamatergic and GABAergic signaling, could
potentially normalize synaptic activity and neural circuit function in
individuals with ASD [T17].
oImmune Modulation: Approaches
aimed at modulating immune responses and reducing neuroinflammation may help
mitigate immune-mediated synaptic dysfunction and restore synaptic homeostasis
in individuals with ASD [T18].
In conclusion,
understanding and addressing the abnormal synaptic homeostasis in Autism
Spectrum Disorders is crucial for developing targeted interventions that can
improve synaptic function, neural connectivity, and cognitive outcomes in
individuals with ASD. By targeting molecular mechanisms, neurotransmitter
imbalances, and immune-mediated synaptic dysfunction, researchers and
clinicians aim to restore synaptic homeostasis and enhance the quality of life
for individuals affected by ASD.
Comments
Post a Comment